Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPKAtsushi Sato, Chifumi Kitanaka, Yoshitaka Narita et al.|Stem Cells Translational Medicine|2012Cited by 185
Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cellsAtsushi Sato, Chifumi Kitanaka, Yoshitaka Narita et al.|Stem Cell Research|2013Cited by 153
MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 AxisAtsushi Satō, Chifumi Kitanaka, Jun Sunayama et al.|Stem Cells|2011Cited by 125
FoxO3a Functions as a Key Integrator of Cellular Signals That Control Glioblastoma Stem-like Cell Differentiation and TumorigenicityJun Sunayama, Chifumi Kitanaka, Atsushi Sato et al.|Stem Cells|2011Cited by 109
Targeting JNK for therapeutic depletion of stem-like glioblastoma cellsKenichiro Matsuda, Chifumi Kitanaka, Atsushi Satō et al.|Scientific Reports|2012Cited by 95